These results suggest that appropriate regulation of the TRIF/RIP-1 pathway and subsequent NF-κB activation may decrease severe corneal damage in viral infections by inhibiting pro-inflammatory cytokines. The gene discussed is RIPK1; the disease is viral infectious disease.